From the Editor's Desk

Can aspirin help protect against colorectal cancers? - National Geographic Premium (No paywall)

Colorectal cancer, a cancer of either the large intestine or rectum, is the third most common type of cancer, and the second most common cause of death from cancer, worldwide. There were 1.9 million new cases diagnosed across the globe in 2020, according to the World Health Organization, and these numbers are expected to grow. In the United States, the rates of colorectal cancers have been rising in people younger than age 50 since the 1990s, which includes more young people dying from the disease, according to the National Cancer Institute. 

Now a new study published in the journal Cancer shows that colorectal cancer patients who took a daily dose of aspirin had a lower rate of metastasis to the lymph nodes and stronger immune response to their tumors. The research suggests that aspirin may be boosting the ability of the immune system to hunt for cancer cells.  

Continued here

TradeBriefs: Newsletters for Decision-Makers!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Want the newsletters, without the promotional mailers?
Get an (ad-free) subscription to TradeBriefs Premium for just $2 per month.